 |
Top 8 Bladder cancer treatment startups in USA
Updated: April 15, 2024 |
1
Funding: $317.6M
CG Oncology is developing the next evolution of oncolytic immunotherapy for patients with advanced cancers.
CG Oncology is developing the next evolution of oncolytic immunotherapy for patients with advanced cancers.
2
Funding: $219.5M
Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.
Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.
3
Funding: $209M
Ikena Oncology is a biotechnology company that advances new immunometabolic therapies for cancer.
Ikena Oncology is a biotechnology company that advances new immunometabolic therapies for cancer.
4
Funding: $205M
Flare Therapeutics is a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases.
Flare Therapeutics is a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases.
5
Funding: $114.2M
TARIS Biomedical a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device convergence products.
TARIS Biomedical a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device convergence products.
6
Funding: $106M
Totus Medicines is a provider of chemical biology technologies by creating life-changing covalent drugs.
Totus Medicines is a provider of chemical biology technologies by creating life-changing covalent drugs.
7
Funding: $73M
OncoCyte focused on cancers with large patient populations and significant unmet need. The company is developing three genetic tests – blood tests for breast cancer and lung cancer, and a urine-based test for bladder cancer.
OncoCyte focused on cancers with large patient populations and significant unmet need. The company is developing three genetic tests – blood tests for breast cancer and lung cancer, and a urine-based test for bladder cancer.
